Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis 2020-12-23 12:30
RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue 2020-12-22 20:38
Overweight and Obese Subjects Dosed with ASC41 Tablets in a Phase Ib Trial 2020-12-22 19:18
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004 2020-12-21 23:00
LT1001 (Naldebain(R)), an Extended-Release Analgesic Injection, Received Its Second Approval from Singapore's HSA 2020-12-21 22:08
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens 2020-12-21 21:00
Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy 2020-12-21 08:00
Antengene Announces Approval of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM 2020-12-18 15:34
Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals 2020-12-18 06:52
dMed Completed a US$100 Million Series C Financing 2020-12-17 13:00
Global UV Cured Resins Market will grow to US$ 7892.70 Mn by 2028 at 8.9% CAGR - says Absolute Markets Insights 2020-12-17 11:00
Harbour BioMed Completes Its Global Offering and Listing on the Hong Kong Stock Exchange 2020-12-17 08:19
Covance, LabCorp's Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials 2020-12-17 00:29
EpiVax Reports Record Year for Immunogenicity Screening Toolkit (ISPRI) 2020-12-16 02:15
RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model 2020-12-16 00:42
ADC Therapeutics and Overland Pharma Form Strategic JV to Expand ADC Drugs Development and commercialization in Greater China and Singapore, Advised by MSQ Ventures 2020-12-15 22:00
PCCS Group Has Reached a Strategic Cooperation With Shenqi Medical to Seek a Grand Blueprint of Medical Health in the Asia-pacific Region 2020-12-15 18:30
Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials 2020-12-15 08:00
Regent Pacific's Commercial Strategic Partner Receives Approval from Taiwan Food and Drug Administration 2020-12-14 20:20
The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment for XLHED, a dermatologic-related rare genetic disease that requires prenatal therapeutic intervention 2020-12-14 09:00
1 139 140 141 142 143 234